JPWO2021163481A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021163481A5 JPWO2021163481A5 JP2022549070A JP2022549070A JPWO2021163481A5 JP WO2021163481 A5 JPWO2021163481 A5 JP WO2021163481A5 JP 2022549070 A JP2022549070 A JP 2022549070A JP 2022549070 A JP2022549070 A JP 2022549070A JP WO2021163481 A5 JPWO2021163481 A5 JP WO2021163481A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- polypeptide
- seq
- nanoparticle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 42
- 108090000765 processed proteins & peptides Proteins 0.000 claims 39
- 239000002105 nanoparticle Substances 0.000 claims 38
- 102000004196 processed proteins & peptides Human genes 0.000 claims 38
- 229920001184 polypeptide Polymers 0.000 claims 37
- 230000035772 mutation Effects 0.000 claims 18
- 102000039446 nucleic acids Human genes 0.000 claims 11
- 108020004707 nucleic acids Proteins 0.000 claims 11
- 150000007523 nucleic acids Chemical class 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 10
- 239000013604 expression vector Substances 0.000 claims 8
- 102000037865 fusion proteins Human genes 0.000 claims 8
- 108020001507 fusion proteins Proteins 0.000 claims 8
- 239000000427 antigen Substances 0.000 claims 6
- 102000036639 antigens Human genes 0.000 claims 6
- 108091007433 antigens Proteins 0.000 claims 6
- 241000342334 Human metapneumovirus Species 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 229960005486 vaccine Drugs 0.000 claims 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 102220086690 rs864622230 Human genes 0.000 claims 4
- 238000006467 substitution reaction Methods 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 3
- 230000002163 immunogen Effects 0.000 claims 3
- 239000013638 trimer Substances 0.000 claims 3
- 102220493139 6-phosphogluconate dehydrogenase, decarboxylating_F32Y_mutation Human genes 0.000 claims 2
- 102220553631 CBY1-interacting BAR domain-containing protein 1_K27N_mutation Human genes 0.000 claims 2
- 102220526139 Dihydrofolate reductase_F32R_mutation Human genes 0.000 claims 2
- 102220570669 E3 ubiquitin-protein ligase MYLIP_S20D_mutation Human genes 0.000 claims 2
- 102220487542 Phospholipase A and acyltransferase 1_L33D_mutation Human genes 0.000 claims 2
- 102220471536 Replication factor C subunit 4_R17D_mutation Human genes 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 230000037431 insertion Effects 0.000 claims 2
- 238000003780 insertion Methods 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102220157709 rs144942998 Human genes 0.000 claims 2
- 102220306159 rs185266383 Human genes 0.000 claims 2
- 102200147810 rs200670692 Human genes 0.000 claims 2
- 102200124760 rs587777729 Human genes 0.000 claims 2
- 102220261975 rs73749738 Human genes 0.000 claims 2
- 102220076188 rs751198815 Human genes 0.000 claims 2
- 230000003248 secreting effect Effects 0.000 claims 2
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 1
- 239000013527 degreasing agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202062977036P | 2020-02-14 | 2020-02-14 | |
US62/977,036 | 2020-02-14 | ||
PCT/US2021/017856 WO2021163481A1 (en) | 2020-02-14 | 2021-02-12 | Polypeptides and their use |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023513592A JP2023513592A (ja) | 2023-03-31 |
JPWO2021163481A5 true JPWO2021163481A5 (es) | 2024-02-19 |
Family
ID=77292738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022549070A Pending JP2023513592A (ja) | 2020-02-14 | 2021-02-12 | ポリペプチド及びそれらの使用(関連出願の相互参照) |
Country Status (10)
Country | Link |
---|---|
US (1) | US20230075095A1 (es) |
EP (1) | EP4103586A4 (es) |
JP (1) | JP2023513592A (es) |
KR (1) | KR20220142471A (es) |
AU (1) | AU2021220958A1 (es) |
BR (1) | BR112022016197A2 (es) |
CL (1) | CL2022002215A1 (es) |
CO (1) | CO2022011395A2 (es) |
PE (1) | PE20230486A1 (es) |
WO (1) | WO2021163481A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023196871A2 (en) * | 2022-04-07 | 2023-10-12 | University Of Washington | Secretion-optimized de novo designed protein nanoparticles for eukaryotic expression and genetic delivery |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2568788A1 (en) * | 2004-06-16 | 2005-12-29 | Dsm Ip Assets B.V. | Production of polypeptides by improved secretion |
US9630994B2 (en) * | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
US10501733B2 (en) * | 2015-02-27 | 2019-12-10 | University Of Washington | Polypeptide assemblies and methods for the production thereof |
JP6957039B2 (ja) * | 2016-09-06 | 2021-11-02 | 学校法人慶應義塾 | 融合タンパク質、構造体、捕集剤、捕集する方法、dna、及びベクター |
US11866699B2 (en) * | 2017-02-10 | 2024-01-09 | University Of Washington | Genome editing reagents and their use |
JP7168938B2 (ja) * | 2017-04-04 | 2022-11-10 | ユニヴァーシティ オブ ワシントン | パラミクソウイルスおよび/またはニューモウイルスのfタンパク質を表示する自己アセンブリするタンパク質ナノ構造およびその使用 |
CN112088014A (zh) * | 2018-02-28 | 2020-12-15 | 华盛顿大学 | 自组装纳米结构疫苗 |
FR3083804B1 (fr) * | 2018-07-13 | 2022-08-12 | Institut Nat Des Sciences Appliquees De Toulouse | Micro-organismes et procede pour la production d'acide glycolique a partir de pentoses et d'hexoses |
-
2021
- 2021-02-12 JP JP2022549070A patent/JP2023513592A/ja active Pending
- 2021-02-12 EP EP21753413.0A patent/EP4103586A4/en active Pending
- 2021-02-12 PE PE2022001740A patent/PE20230486A1/es unknown
- 2021-02-12 AU AU2021220958A patent/AU2021220958A1/en active Pending
- 2021-02-12 KR KR1020227031325A patent/KR20220142471A/ko unknown
- 2021-02-12 US US17/760,180 patent/US20230075095A1/en active Pending
- 2021-02-12 BR BR112022016197A patent/BR112022016197A2/pt unknown
- 2021-02-12 WO PCT/US2021/017856 patent/WO2021163481A1/en active Application Filing
-
2022
- 2022-08-12 CL CL2022002215A patent/CL2022002215A1/es unknown
- 2022-08-12 CO CONC2022/0011395A patent/CO2022011395A2/es unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018509935A5 (es) | ||
JP2020523321A5 (es) | ||
JP2020517635A5 (es) | ||
JP6734651B2 (ja) | マラリアワクチン | |
JP2017538395A5 (es) | ||
JP2014506450A5 (es) | ||
JP2018537087A5 (es) | ||
JP2018504412A5 (es) | ||
JP2003530123A (ja) | B型肝炎コア抗原融合タンパク質 | |
JP2009501012A (ja) | 伝染性ファブリキウス嚢病ウイルス(ibdv)に由来する中空キメラ性ウイルス様粒子、これらの製造および応用 | |
JP2012516140A5 (es) | ||
JP2019535310A5 (es) | ||
JP2010535504A5 (es) | ||
JPWO2021163481A5 (es) | ||
US9676825B2 (en) | Chimeric vaccine antigens against hepatitis C virus | |
WO2023111728A1 (es) | Péptidos inmunogénicos contra el virus distemper canino (cdv) | |
JP2014515595A5 (es) | ||
JP2018505697A5 (es) | ||
JP2020536925A5 (es) | ||
WO2023283412A1 (en) | Compositions and methods to increase coronavirus immune response | |
JP2020511140A5 (es) | ||
JP2020526202A5 (es) | ||
JP2003507011A5 (es) | ||
JP5000807B2 (ja) | 体細胞導入遺伝子免疫および関連方法 | |
Sarfaraz et al. | Recent Updates on Peptide Molecules in Drug and Vaccine Development |